“…Stimulation of the phago cytic activity of the RES before tumour cell challenge will improve host resistance to tumour growth [8,16]. On the other hand, depression of the functions of the macro phages constituting the RES will compromise host survival to tumour challenge [6,12]. Cytostatic drugs, clinically used in anti-can cer treatment, have recently been reported to impair the phagocytic function of the RES [11,18].…”